Drugs Made In America Acquisition II annual shares outstanding
2024
2025
Drugs Made In America Acquisition II Shares Outstanding History (DMII)
Drugs Made In America Acquisition II reported 13.7M shares outstanding at the end of fiscal 2025.
View full Drugs Made In America Acquisition II company overviewDrugs Made In America Acquisition II annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 13.7M | −50.0M | −78.49% |
| 2024 | 2024-12-31 | 63.7M | — | — |
Drugs Made In America Acquisition II quarterly shares outstanding
As of Dec 31, 2024
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 13.7M | −50.0M | −78.49% |
| Q1 2026 | 2026-03-31 | 13.7M | −50.0M | −78.49% |
| Q4 2025 | 2025-12-31 | 13.7M | −675,000 | −4.70% |
| Q3 2025 | 2025-09-30 | 15.6M | — | — |
| Q2 2025 | 2025-06-30 | 63.7M | — | — |
| Q1 2025 | 2025-03-31 | 63.7M | — | — |
| As of Dec 31, 2024 | 2024-12-31 | 14.4M | — | — |
Drugs Made In America Acquisition II shares outstanding trends
Between the periods ended 2024-12-31 and 2025-12-31, Drugs Made In America Acquisition II's shares outstanding moved from 63.7M to 13.7M, a change of −50.0M. The latest reported quarter, Q2 2026, shows 13.7M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when a stock-split conversion ratio is reported directly or evidenced by a later filing’s restated historical share balance. After repeated reverse splits, an old period can represent less than one current-basis share; this is a split-adjusted equivalent, not a literal historical certificate count. Values remain as reported when no reliable split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Drugs Made In America Acquisition II source filings ↗